Antithrombotic Therapy After Transcatheter Aortic Valve Implantation

Overview

Journal Eur Cardiol

Specialty Cardiology & Vascular Diseases

Date 2020 Mar 18

PMID 32180830

Citations 4

Authors

Leslie Marisol Lugo

Rafael Romaguera

Joan Antoni Gomez-Hospital

Jose Luis Ferreiro

Affiliations

Soon will be listed here.

Abstract

The development of transcatheter aortic valve implantation has represented one of the greatest advances in the cardiology field in recent years and has changed clinical practice for patients with aortic stenosis. Despite the continuous improvement in operators' experience and techniques, and the development of new generation devices, thromboembolic and bleeding complications after transcatheter aortic valve implantation remain frequent, and are a major concern due to their negative impact on prognosis in this vulnerable population. In addition, the optimal antithrombotic regimen in this scenario is not known, and current recommendations are mostly empirical and not evidence based. The present review aims to provide an overview of the current status of knowledge, including relevant on-going randomised trials, on antithrombotic treatment strategies after transcatheter aortic valve implantation.

Citing Articles

Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: An Overview.

Hindi M, Akodad M, Nestelberger T, Sathananthan J Struct Heart. 2023; 6(5):100085.

PMID: 37288058 PMC: 10242582. DOI: 10.1016/j.shj.2022.100085.

Non-Vitamin K Oral Anticoagulant After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.

Li D, Ma X, Zhou X, Qian Y Front Pharmacol. 2022; 13:755009.

PMID: 35222019 PMC: 8880334. DOI: 10.3389/fphar.2022.755009.

Platelets: Implications in Aortic Valve Stenosis and Bioprosthetic Valve Dysfunction From Pathophysiology to Clinical Care.

Sellers S, Gulsin G, Zaminski D, Bing R, Latib A, Sathananthan J JACC Basic Transl Sci. 2022; 6(12):1007-1020.

PMID: 35024507 PMC: 8733745. DOI: 10.1016/j.jacbts.2021.07.008.

Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement: the complexity of the elderly.

Bencivenga L, Sepe I, Palaia M, Komici K, Corbi G, Puzone B Eur J Prev Cardiol. 2021; 28(1):87-97.

PMID: 33624104 PMC: 7665487. DOI: 10.1093/eurjpc/zwaa053.

References

Yong Z, Wiegerinck E, Boerlage-van Dijk K, Koch K, Vis M, Bouma B . Predictors and prognostic value of myocardial injury during transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2012; 5(3):415-23. DOI: 10.1161/CIRCINTERVENTIONS.111.964882. View

Mack M, Leon M, Thourani V, Makkar R, Kodali S, Russo M . Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019; 380(18):1695-1705. DOI: 10.1056/NEJMoa1814052. View

Nara Y, Watanabe Y, Kataoka A, Nakashima M, Hioki H, Nagura F . Incidence, Predictors, and Midterm Clinical Outcomes of Myocardial Injury After Transcatheter Aortic-Valve Implantation. Int Heart J. 2018; 59(6):1296-1302. DOI: 10.1536/ihj.17-645. View

Kappetein A, Head S, Genereux P, Piazza N, Van Mieghem N, Blackstone E . Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012; 60(15):1438-54. DOI: 10.1016/j.jacc.2012.09.001. View

Tchetche D, Farah B, Misuraca L, Pierri A, Vahdat O, LeReun C . Cerebrovascular events post-transcatheter aortic valve replacement in a large cohort of patients: a FRANCE-2 registry substudy. JACC Cardiovasc Interv. 2014; 7(10):1138-45. DOI: 10.1016/j.jcin.2014.04.018. View

Genereux P, Cohen D, Mack M, Rodes-Cabau J, Yadav M, Xu K . Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. J Am Coll Cardiol. 2014; 64(24):2605-2615. DOI: 10.1016/j.jacc.2014.08.052. View

Vranckx P, Windecker S, Welsh R, Valgimigli M, Mehran R, Dangas G . Thrombo-embolic prevention after transcatheter aortic valve implantation. Eur Heart J. 2017; 38(45):3341-3350. DOI: 10.1093/eurheartj/ehx390. View

Amat-Santos I, Rodes-Cabau J, Urena M, DeLarochelliere R, Doyle D, Bagur R . Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol. 2011; 59(2):178-88. DOI: 10.1016/j.jacc.2011.09.061. View

Bosmans J, Bleiziffer S, Gerckens U, Wenaweser P, Brecker S, Tamburino C . The Incidence and Predictors of Early- and Mid-Term Clinically Relevant Neurological Events After Transcatheter Aortic Valve Replacement in Real-World Patients. J Am Coll Cardiol. 2015; 66(3):209-217. DOI: 10.1016/j.jacc.2015.05.025. View

10.

Noble S, Asgar A, Cartier R, Virmani R, Bonan R . Anatomo-pathological analysis after CoreValve Revalving system implantation. EuroIntervention. 2009; 5(1):78-85. DOI: 10.4244/eijv5i1a12. View

11.

Ruff C, Giugliano R, Braunwald E, Hoffman E, Deenadayalu N, Ezekowitz M . Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2013; 383(9921):955-62. DOI: 10.1016/S0140-6736(13)62343-0. View

12.

Nishimura R, Otto C, Bonow R, Carabello B, Erwin 3rd J, Fleisher L . 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017; 70(2):252-289. DOI: 10.1016/j.jacc.2017.03.011. View

13.

Ussia G, Scarabelli M, Mule M, Barbanti M, Sarkar K, Cammalleri V . Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2011; 108(12):1772-6. DOI: 10.1016/j.amjcard.2011.07.049. View

14.

Stefanini G, Stortecky S, Cao D, Rat-Wirtzler J, OSullivan C, Gloekler S . Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation. Eur Heart J. 2014; 35(37):2530-40. DOI: 10.1093/eurheartj/ehu074. View

15.

Dangas G, Weitz J, Giustino G, Makkar R, Mehran R . Prosthetic Heart Valve Thrombosis. J Am Coll Cardiol. 2016; 68(24):2670-2689. DOI: 10.1016/j.jacc.2016.09.958. View

16.

Chakravarty T, Sondergaard L, Friedman J, De Backer O, Berman D, Kofoed K . Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 2017; 389(10087):2383-2392. DOI: 10.1016/S0140-6736(17)30757-2. View

17.

Leon M, Smith C, Mack M, Makkar R, Svensson L, Kodali S . Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016; 374(17):1609-20. DOI: 10.1056/NEJMoa1514616. View

18.

Overtchouk P, Guedeney P, Rouanet S, Verhoye J, Lefevre T, Van Belle E . Long-Term Mortality and Early Valve Dysfunction According to Anticoagulation Use: The FRANCE TAVI Registry. J Am Coll Cardiol. 2018; 73(1):13-21. DOI: 10.1016/j.jacc.2018.08.1045. View

19.

Cerrato E, Nombela-Franco L, Nazif T, Eltchaninoff H, Sondergaard L, B Ribeiro H . Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey. Int J Cardiol. 2016; 228:640-647. DOI: 10.1016/j.ijcard.2016.11.104. View

20.

Paradis J, Maniar H, Lasala J, Kodali S, Williams M, Lindman B . Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves). JACC Cardiovasc Interv. 2015; 8(11):1468-1479. PMC: 4624400. DOI: 10.1016/j.jcin.2015.06.018. View